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Abstract 
The ageing population poses new challenges globally. Cancer care for the older patient is one 
of these challenges and it has a significant impact on societies. In the United Kingdom (UK), 
as the number of older cancer patients increases, the management of this group became part of 
daily practice for most oncology teams in every geographical area. Older cancer patients are at 
a higher risk of both under- and over-treatment. Therefore, the assessment of a patient’s  
biological age and effective organ functional reserve becomes paramount. This may then guide 
treatment decisions by better estimating prognosis and the risk to benefit ratio of a given therapy 
to anticipate and mitigate against potential toxicities/difficulties. Moreover, older cancer 
patients are often affected by geriatric syndromes and other issues that impact their overall 
health, function and quality-of-life. Comprehensive geriatric assessments offer an opportunity 
to identify and address health problems which may then optimise one’s fitness and wellbeing. 
Whilst it is widely accepted that older cancer patients may benefit from such an approach, 
resources are often scarce and access to dedicated services and research remains limited to 
specific centres across the UK. The aim of this project is to map the current services and projects 
in the UK in order to learn from each other and shape the future direction of care of older 
patients with cancer.  
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1- Introduction 
Cancer is mostly a disease of older adults with about 60% of cases diagnosed in those aged 65 
years and above (1). In the United Kingdom (UK) the number of older adults living with a 
cancer diagnosis in 2010 was 1.3 million but this is rapidly increasing and is estimated to reach 
4.1 million by 2040 (2). Older cancer patients can have wider health needs and are the majority, 
in fact, they represent everyday practice for oncologists across multiple cancer sites. The 
growing number of older cancer patients increases the demand on the National Health Service 
(NHS). Ageing is associated with increasing frailty which, in turn, may increase complexity of 
care. Importantly, UK law is clear that age discrimination must not occur (Equality Act 2010 
Order 2012) and therefore the NHS cannot (and should not) provide inferior services solely 
because of a patient’s age. In the context of these important epidemiological and sociological 
drivers there has been a significant effort in recent years accross different sectors in the UK to 
improve care and research for older cancer patients.  
 
2- National Health Service (NHS) 
In 2018, the NHS (England, Wales and Scotland) marked its 70th anniversary and the NHS 
England Long Term Plan was developed (3). This plan identified improving care for all older 
people living with frailty (such as cancer patients) as a priority. It includes enhancing health 
within care homes and also strengthening community teams to be more proactive and to support 
patients at home during a crisis. Specifically for cancer patients, one key aim has been to deliver 
a comprehensive model for personalised care with needs assessment and further integration of 
Clinical Nurse Specialists and other support workers, alongside increased community-based 
support. It is therefore hoped that the care for frail cancer patients, who are mostly older, should 
have a significant boost in resources in the coming years. In this context, and as part of NHS 
England RightCare Pathways, the NHS RightCare Frailty Toolkit was published in 2019 (4). 
This resulted from a collaboration with National Clinical Director for Older People at NHS 
England, the charity Age UK, the NHS improvement program Getting It Right First Time 
(GIRFT) and the National Institute for Health and Care Excellence (NICE). This toolkit 
provides expert guidance on how to commission and provide the best system-wide care for 
people living with frailty. In essence it helps us to understand the priorities in frailty 
identification and care, provides a benchmark and identifies key actions for improvement. 
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3- Specialized Clinical Frailty Network (SCFN) 
Frailty is a state of increased vulnerability to poor resolution of homoeostasis after a stressor 
event, which increases the risk of adverse outcomes. Moreover, frailty is associated with ageing 
hence that in 2018, NHS Elect was commissioned to deliver the SCFN in England. This is a 
clinically led quality improvement collaborative working with specialised teams across 
different medical areas to explore how frailty assessment and management can best be 
integrated. This network was launched following the success of the Acute Frailty Network 
developing front door frailty services in secondary care. A key element is the integration of the 
Rockwood Clinical Frailty Scale (CFS) in routine clinical assessments (5). This 9-levels scale 
provides a quick and simple method to identify frailty and is based on how active and 
independent patients are on their daily life activities. The first wave of specialized services 
started in late 2018 and included 5 cancer services across England, focusing mainly on patients 
with lung cancer being considered for chemotherapy. More recently, in late 2019, the third wave 
was launched and expanded the scope to cancer surgery services with a focus on gynaecological 
cancer. Following on from the collaborative work developed within the first two waves, the 
Specialized Clinical Frailty Toolkit was launched (6). This Toolkit is not exclusive to oncology 
and is targeted at anyone working with older people with frailty and involved in the design and 
delivery of specialized services. The aim is to provide guidance on how to develop the most 
appropriate pathways for frail patients within specialised services to optimise their outcomes.  
 
4- Cancer Charities 
In 2015 the cancer charity Macmillan convened a multidisciplinary Expert Reference Group 
(ERG) in Cancer in the Older Person. This group scoped current assessment methods employed 
across the UK in cancer services and used this along with a nominal consensus approach to 
come to an expert consensus on the optimal Geriatric Oncology assessment tool for use in the 
UK (7). The ERG also produced a consultation document (8) highlighting the need to educate 
the NHS workforce in issues pertinent to older people. Mutual education was recommended 
with geriatric specialists being upskilled in oncological issues and vice versa. To facilitate this, 
the ERG developed educational sessions and material for primary care teams and other health 
care professionals, and it also coordinated study days with the British Geriatric Society. 
Moreover, whilst being involved in the international Delphic process to establish the core 
curriculum in Geriatric Oncology, it promoted changes in the training curricula for Medical and 
Clinical Oncologists in the UK. Beyond promoting education, the Macmillan ERG played a 
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role in the development of specific recommendations in NHS England Cancer Strategy plan for 
2015-2020. These include, piloting a comprehensive care program for older people with cancer 
(holistic needs assessment and comprehensive geriatric assessment (CGA)) and to develop 
dedicated research protocols (9).  
 
Cancer Research UK is the largest cancer charity in the UK and, whilst it has no funding stream 
dedicated to geriatric oncology, it produced a report in 2018 on how to prepare for the increasing 
number of older patients (10). This report echoed calls to assess frailty, implement CGA and 
introduce new processes in multidisciplinary team meetings. The report also asked for policy 
changes to NHS waiting-time targets, arguing that in older patients the time spent before 
treatment in assessing and optimising fitness was valuable, yet potentially discouraged by these 
targets which mandate a rapid start of treatment. 
 
5- National Cancer Research Institute (NCRI) 
Research is key and the NCRI has been committed, through its working groups, to support 
research that considers the distinct issues of older people. The NCRI conducted a scoping 
exercise for priorities in Living with and Beyond Cancer. Priority number 3 focuses on how to 
better coordinate care for people with complex needs living with and beyond cancer (11). 
Moreover, the NCRI developed an important workshop highlighting these issues and 
suggesting ways to optimise research design for older cancer patients (12, 13).  
 
6- Professional Societies 
The British Geriatrics Society (BGS) was founded in the UK in 1947 and is a multidisciplinary 
society that welcomes everyone specialising in the healthcare of older people. In 2015, the BGS 
Special Interest Group in Geriatric Oncology was founded. It is open to any healthcare 
professionals involved in the care of older cancer patients and aims to promote education, 
training and research in the field. Its longer-term aims include an e-learning package for 
geriatricians, sharing examples of good practice and providing practical advice on how to 
develop business cases. 
On the global stage, the UK has been actively involved within the International Society of 
Geriatric Oncology (SIOG), which was founded in 2000 and is growing rapidly. This 
multidisciplinary group’s sole purpose is to promote geriatric oncology and optimise the 
treatment of older adults with cancer. SIOG promotes efforts in 3 strategic directions: 
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education, clinical practice and research. Its original 10 Priorities proposal from 2011 is 
currently being revised and publication is expected soon, which is an important initiative to 
advocate for better care and research in this field (14). Lastly, SIOG’s dedicated Journal of 
Geriatric Oncology has disseminated many guidelines and practice changing research outcomes 
worldwide. The UK is continuously represented at SIOG through its National Representative 
and also with members at the governance level. 
 
7- National audits in geriatric oncology 
National audits are a good opportunity to understand practice and outcomes across the UK. The 
National Audit of Breast Cancer in Older Patients (NABCOP) is a comprehensive and ongoing 
study of pathways of care and outcomes for women diagnosed with breast cancer over the age 
of 70 (with comparative data obtained from a cohort of women aged 50-69). The audit has now 
produced a third annual report which has highlighted significant disparities in care (15). 
NABCOP has been successful in implementing the Rockwood CFS assessment as a field within 
the National Cancer Data Registry, making it the first disease site to mandate collection of these 
data through a national dataset.  
 
8- Geriatric Oncology services and projects across the UK (Fig. 1) 
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Legend: 
 
1- Brighton (Sussex Cancer Centre - Brighton and Sussex University Hospitals NHS Trust) 
2- London (Guy’s and St. Thomas’ NHS Foundation Trust; University College London Hospitals NHS 
Foundation Trust) 
3- Cambridge (Cambridge University Hospitals NHS Foundation Trust) 
4- Nottingham (Nottingham University Hospitals NHS Trust) 
5- Sheffield (Sheffield Teaching Hospitals NHS Foundation Trust) 
6- Manchester (The Christie NHS Foundation Trust; Manchester University NHS Foundation Trust) 
7- Leeds (Leeds Teaching Hospitals NHS Trust) 
8- Hull (Queen’s centre for Oncology and Haematology - Hull University Teaching Hospitals NHS Trust) 
9- Newcastle upon Tyne (Newcastle upon Tyne Hospitals NHS Foundation Trust) 
10- Dundee (Ninewells Hospital - NHS Tayside) 
11- Glasgow (Beatson West of Scotland Cancer Centre) 
12- Belfast (Belfast Health and Social Care Trust - NHS Greater Glasgow and Clyde) 
13- Swansea (South West Wales Cancer Centre, Swansea Bay University Health Board) 
14- Cardiff (Cardiff and Vale University Health Board) 
 
FIG 1. Geographic representation of key services and projects 
 
 
8.1- England 
NHS England is comprised of 7 regional teams according to geographic areas which serve a 
population of approximately 56 million people. Cancer care is coordinated at a more local level 
through 20 Cancer Alliances which bring together key organisations in their areas.  
 
Brighton 
The Brighton and Sussex University Hospitals Trust developed a joint geriatric-breast surgery 
clinic which is staffed by a surgeon and a geriatrician. This runs in parallel with a specialist 
oncology clinic and with support from breast cancer nurse specialists. Patients are referred at 
the start of their pathway if they are potentially unfit for, or they decline, standard treatment 
for breast cancer. There are no specific age-based referral criteria. Patients are jointly assessed 
by the breast surgeon and geriatrician who undertakes an abbreviated CGA focussed on 
management of co-morbidities, functional status, polypharmacy, cognitive function, mood 
and social support. Following this joint assessment, the clinicians formulate a management 
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plan with options that are discussed with the patient in a shared decision-making approach. 
For the patients planned for surgery an anaesthetic review is also arranged.  
In the period between April 2015-March 2020, a total of 182 breast cancer patients were seen. 
First appointments averaged 45 minutes to include an abbreviated CGA, evaluation of breast 
cancer and discussion of diagnosis and management plan. Mean age was 82 years (range 69-
99 years). 57% of patients had subsequent assessments/reviews (between 1-6 times), which 
averaged 25 minutes duration. Regarding their outcomes, 13% of patients were referred for 
surgery and in 35% the medical management was changed, typically for treatment 
optimisation, further investigations or referral to other specialists (16).  
Future plans for the clinic include providing diagnostic clinics for patients identified as frail and 
for the joint care of suitable patients with advanced disease. 
 
Cambridge 
Cambridge University Hospitals NHS Foundation Trust (CUH) addressed the problem that 
ECOG and Karnofsky performance status scales, which are routinely used, are problematic in 
assessing older cancer patients pre-treatment. In 2016, they explored how the Rockwood CFS, 
which was developed in the acute/community setting, would perform in routine outpatient 
cancer clinics. A total of 114 cancer patients were assessed using these 3 clinical tools. The 
CFS was the best tool at differentiating patients bellow and above 70 years (p=0.0056) followed 
by the Karnofsky (p=0.02), whilst the ECOG performance status found no differences (17).  
In 2018, the CUH lung cancer team joined the SCFN led by NHS Elect in England as one of 5 
pilot oncology teams. The team implemented a questionnaire incorporating the CFS and 
covering the different domains of CGA. This was divided in 2 parts, the first being patient-led 
and the second healthcare professional-led. It was targeted at all new advanced lung cancer 
patients being considered for systemic anti-cancer treatment with an ECOG performance status 
of 2+. The Rockwood CFS was used as a complementary measure, but not to determine who 
might benefit from CGA. Ultimately, the team aimed at mapping frailty and the domains 
affected in order to better inform treatment decisions. This work further supported the use of 
CFS which provided more granularity compared with the conventional ECOG performance 
status. Moreover, the team reported that the information provided by these additional 
assessments helped tailoring treatment decisions, medicine discontinuation and appropriate 
referrals to therapists. It also highlighted a significant burden of physical and psychological 
factors contributing to frailty.  
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Hull 
The Queen’s centre for Oncology and Haematology in conjunction with Transform group from 
the Hull York medical school (funded by Yorkshire Cancer research) are developing a 
programme of research in tandem with a service development for older cancer patients. Their 
initial research was to look at the feasibility of CGA in an oncology outpatient setting (18). At 
present, they are in the process of developing an Oncogeriatric service for patients with 
established or suspected cancer before they are discussed at multi-disciplinary meetings so that 
decision about cancer care can be better made. Ultimately this will involve collecting the data 
by smartphone or tablet apps.  
The team is also developing a programme of tailored nutrition and exercise intervention for 
those over 70 years old with lung cancer (CanBenefit) to improve symptoms and fitness for 
systemic cancer therapy. Lastly, the team is also planning to address the barriers to clinical trial 
entry for these older cancer patients with a mixture of systematic reviews and stakeholder 
involvement. 
 
Leeds 
The Clinical Trials Unit in Leeds coordinated the recently published GO2 trial (19). This is a 
multicentre phase 3 trial which compared 3 different doses of oxaliplatin and capecitabine in 
514 frail/elderly patients with advanced gastro-oesophageal cancer and a definite indication for 
chemotherapy. This study recruited patients between 2014-2017 across 61 UK centres. In this 
trial a comprehensive health assessment was performed prior to randomisation and the study 
included a novel outcome measure, overall treatment utility (OTU). OTU is a composite 
endpoint derived from both clinical and patient reported outcomes and is scored as good, 
intermediate or poor. A good OTU is achieved if: 1) there is an absence of disease progression 
(clinical and radiological), and 2) there is no significant toxicity and good patient acceptability.  
The presence of one adverse outcome results in an intermediate OTU and both a poor OTU. 
This population had a median age of 76 years and 58% were scored as being very frail. The 
trial concluded that the lowest dose of chemotherapy achieved the highest rates of good OTU. 
Initial analysis found that paradoxically the least frail and better performance status patients 
gained most from reducing dose of chemotherapy while age was not associated with worse 
outcomes. This trial confirmed that it is feasible to recruit frail/elderly patients into clinical 
trials. Moreover, it questions the long-held oncology paradigm that systemic anticancer therapy 
dosing should be based on maximum tolerated doses. Future trials are needed to identify 
minimal effective dosing for the elderly/frail patients in other cancer sites.  
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London 
At Guy’s and St. Thomas’ NHS Foundation Trust the Geriatric-Oncology Liaison Development 
(GOLD) service was a pioneer in the UK. It was established with a clear aim: to facilitate equity 
for older people's cancer treatment decision-making, based on fitness for treatment and 
patient choice rather than chronological age. An initial screening questionnaire identifies 
medical, functional and/or psychosocial problems (20). These are then addressed in a 
multidisciplinary outpatient clinic with geriatrics-trained doctors and nurses, and occupational 
therapy and physiotherapy where needed, to deliver an optimisation plan for older patients 
undergoing cancer treatment. In the current model, GOLD identifies patients needing CGA 
interventions by both a referral-based model but also by active case-finding using the geriatric 
assessment tool developed by UK ERG and delivered by allied health professionals in a number 
of clinical areas (e.g. radiotherapy, chemotherapy unit, acute oncology). GOLD clinical reviews 
with a multidisciplinary team are largely “one-stop” face-to-face but with a number of other 
actions being managed remotely or through nurse-led telephone clinics. Patients are seen 
within 1-3 weeks of referral, often faster in order not to impact cancer treatment waiting 
times. Mostly patients aged 70+ are seen but also younger patients (age 55+) as it became 
evident that biologically frail younger patients with poor performance status and/or multi-
morbidity had similar CGA needs. A key element of this integrated service involves linking up 
all primary and secondary care providers. In fact, this fills a gap where local GPs described that 
they tended to lose sight of older cancer patients once they have been referred to oncology. 
The GOLD service has proven successful by demonstrating that more older patients (aged 70+) 
completed chemotherapy as planned (OR 4.14, p=0.006) and fewer required treatment 
modifications (OR 0.34, p=0.006). Overall grade 3+ toxicity rates were 43.8% in those receiving 
GOLD service support compared to 52.9% in those receiving usual care (21). Moreover, 62.5% 
of oncologists reported that GOLD influenced decision-making. Of these, 67% reported GOLD 
assisted in the evaluation of fitness for treatment, more often in favour of active treatment 
(22).  
A number of new clinical pathways have been successfully embedded across areas within 
oncology and haemato-oncology via quality improvement projects. One example is a pathway 
with prostate cancer nurse specialist-led clinics whereby all patients over age 70 on anti-
androgen therapy are referred for vascular, bone health and comorbidity risk assessment (23). 
Lastly, in regard to the inpatient setting, the team piloted a model with daily GOLD clinical 
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nurse specialist visits and clinical fellow rounds demonstrating a significant reduction in 
average length of stay. 
 
Other centres, such as the University College London Hospitals NHS Foundation Trust (UCLH), 
have also been developing services for older cancer patients particularly as part of the SCFN 
led by NHS Elect in England since late 2018. The focus at UCLH has been mostly on lung cancer 
patients admitted to oncology wards where these have been screened by the oncology 
medical team using the Rockwood CFS. This triggers a referral to the Geriatrics Team for a CGA 
which is then discussed at a newly piloted Frailty multidisciplinary team meeting. 
 
 
Manchester 
The Christie NHS Foundation Trust is a standalone cancer centre without a geriatrics 
department. However, the Oncology of Later Life Group was set-up in 2015 as a multi-
professional group of individuals aiming to support and coordinate project in geriatric 
oncology. The initial focus was to build awareness locally, followed by the development of an 
annual Onco-Geriatrics Study Day since 2018. Currently, a business case is underway to 
develop a frailty team for a multilevel approach. Key data to support this business case was 
derived from the SCFN quality improvement project as the lung team joined this project led by 
NHS Elect in 2018. The Rockwood CFS was incorporated as an electronic tool within the 
standard outpatient assessment for all new lung cancer patients. Over 1000 patients have been 
screened since then with about 40% being vulnerable or frail (CFS 4+). Frailty correlated with 
ageing (p<0.01) and a worse ECOG PS  (p<0.01) (24). These patients were also 20-30% less 
likely to be offered systemic anti-cancer treatment and less likely to continue beyond 1 cycle 
of treatment with more admissions. This highlighted the need for improvement in patient 
optimization, selection and support. Therefore, the use of the CFS is being expanded across the 
trust. The team is currently working to validate this tool for use in cancer patients within the 
outpatient setting, since this was not how it was originally developed. The gynaecological 
surgery team is part of the third wave of the SCFN, with the CFS incorporated into MDT 
referrals and pre-op assessments. 
 
Meanwhile, the first dedicated onco-geriatrics clinic in Greater Manchester started in 
October2018 at Wythenshawe Hospital (Manchester University NHS Foundation Trust). This 
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focused on lung cancer patientsand all new cases aged 65+ are screened by health care 
assistants using the geriatric 8 (G8) tool. Those who fail screening are booked for a CGA, but 
direct referrals are also accepted. The clinic is geriatrician-led, but patients benefit from 
subsequent referrals to allied health professionals for targeted interventions as needed. The 
ultimate aim is to create a multi-disciplinary team. The integration of a new service is often a 
slow process and whilst less than 100 patients were assessed, since this service was 
implemented the number of patients completing optimal adjuvant chemotherapy saw a 15% 
increase. 
In parallel, the ambition to improve cancer outcomes in Greater Manchester has led to the 
development of Prehab4Cancer. It was launched in April 2019 and is the first system-wide 
prehabilitation and rehabilitation service for cancer patients in the UK. It focuses on optimising 
physical fitness and strength, nutrition and psychological well-being. Cancer patients undertake 
community-based prehabilitation and recovery close to their residential address, accessing the 
service in one of the 86 public leisure facilities overseen by Greater Manchester Active. Over 
800 patients undergoing major surgical resection for colorectal, oesophago-gastric and lung 
cancers have participated in Prehab4Cancer in its first year as a standard of care. 65% of 
participants were aged 70+ and results showed that it is most useful in older patients (25). This 
programme is now planned to be extended to non-surgical cancer patients as well. 
 
In regard to research, in the medical oncology field, the ELDERS study was developed at The 
Christie focusing on the role of immunotherapy with checkpoint inhibitors in older patients 
with advanced cancer. This single site, prospective cohort study enrolled 140 patients with 
advanced lung cancer or melanoma. The primary endpoint is safety (incidence of moderate-
severe immune-related adverse events), while quality of life is the key secondary endpoint. This 
is the first study in the field of immunotherapy to focus on older cancer patients, while also 
incorporating frailty and geriatric assessments. The final results are expected to be published in 
2020. Moreover, in the surgical field, the GOSAFE trial (Geriatric Oncology Surgical 
Assessment and Functional rEcovery after Surgery) is a real-life observational study which 
defined quality-of-life and functional recovery as its primary outcomes (26). The hepatobiliary 
and pancreatic cancer unit at Manchester Royal Infirmary (Manchester University Hospitals 
NHS Foundation Trust) was the only centre in the UK recruiting patients to this large 
international trial where a total of 1003 patients aged 70+ were recruited. The final results are 
also expected in 2020.  
 13 
Newcastle upon Tyne 
Newcastle upon Tyne Hospitals NHS Foundation Trust performed several practice audits which 
confirmed that across a number of different tumour types, older patients were at higher risk of 
toxicity and have lower rates of active treatment, particularly chemotherapy (27-29).  
In 2018, the lung team also joined the SCFN led by NHS Elect and implemented the Rockwood 
CFS early on in the cancer pathway to all those presenting with potential lung cancer (30). 
Whilst not having a dedicated team for older cancer patients, similarly to the other sites within 
this network, the implementation of this tool was considered useful to the team and generated 
more in-depth discussions. Targeted interventions were then performed by occupational 
therapist on site. The pilot for early assessment in lung cancer outpatient clinics is ongoing 
whilst experience in an outpatient clinical trials unit showed a high level of demand with 
significant potential for early intervention (31).  The implementation of the Rockwood CFS has 
been extended to other tumour types and to those admitted to oncology wards.  
Research in onco-geriatrics is facilitated by the hospital’s close links with the Newcastle 
University Institute of Ageing and the NIHR Newcastle Biomedical Research Centre. The 
Newcastle 85+ study is a cohort study of people in the community aged 85+ who do not 
necessarily have a diagnosis of cancer. In this cohort a series of blood tests have been shown to 
predict frailty and subsequent mortality (32). Pilot work then showed key differences in these 
blood tests in patients with lung cancer from the Newcastle 85+ cohort and showed that they 
can predict mortality (33). In addition, sarcopenia is a key element of frailty and this was 
investigated in Newcastle by assessing grip strength which when adjusted for age and gender 
has prognostic value in cancer patients awaiting clinical trials (34). Sarcopenia can also be 
assessed by muscle bulk on CT scan and the radiology team developed a simple methodology 
to minimise intra- and interobserver variability that can be used both in clinical trials and routine 
practice (35). 
 
Nottingham 
The Nottingham University Hospitals NHS Trust established the “SCOPES oncology” service 
(Systematic Care for Older People in Elective Surgery) in 2013. This is based on a model 
originally set up for older people undergoing elective orthopaedic procedures. The concept was 
extended to patients with upper gastrointestinal cancers who are being considered for curative 
surgery. In this setting, older patients (no age criteria but mostly 70+) and/or those with complex 
co-morbidities can be referred for a geriatrician-led CGA, performed with the support of an 
upper gastrointestinal specialist nurse and the dietetics service. Ultimately this team performs 
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a fitness assessment and delivers interventions to optimise patients prior to surgery, promoting 
a timely post-operative recovery. More recently, this team has also been running a clinic for 
older patients suspected to have a malignancy, who require further investigations. This provides 
an opportunity to assess fitness for cancer treatments, to discuss the risk/benefit of further 
invasive investigations and to intervene/optimise patients in preparation for potential 
treatments. Moreover, the team is setting up a pilot for a prehabilitation service specific for lung 
and hopefully upper gastrointestinal cancer patients who are about to undergo treatment. The 
plan is that this will incorporate physical activity, nutrition, smoking cessation and 
psychological support. Similar to other regions in the UK, the aim is to use community sports 
facilities to make the service more local to patients.  In August 2019, a Clinical Fellowship post 
in Geriatric Oncology was established with the aim to nurture the role of geriatricians imbedded 
in an oncology department.  
 
The University of Nottingham is also actively involved in the field and leads a unique 
programme on primary breast cancer in older women. The research programme has the 
overarching goal of optimising the management of primary breast cancer in older women and 
consists of 3 themes including the areas of breast cancer biology, geriatric assessment, quality-
of-life and health economics. The program offers opportunities to pursue a PhD in the field and 
the team has presented its work at numerous national and international conferences, in particular 
at the annual SIOG meeting. Leading on from this, the region is host to the “Symposium on 
Primary Breast Cancer in Older Women”. This is a biennial event running since 2010 organized 
by the University of Nottingham, in association with SIOG.  
 
Sheffield 
The Sheffield Teaching Hospitals NHS Foundation Trust has also been actively involved in the 
SCFN, led by NHS Elect in England since late 2018. The Rockwood CFS was initially 
implemented in 116 lung cancer patients within chemotherapy clinics. In this cohort, age was 
not associated with CFS; 43% of patients were classed as CFS 4-6 whilst only 1 patient was 
CFS 7-9, probably because very frail patients are not usually referred for chemotherapy; those 
with a CFS 4+ had longer admissions to hospital and were more likely to die within 30 days of 
chemotherapy. Subsequently, CFS was measured in a cohort of 103 new lung cancer patient 
referred to oncology clinic. In this cohort, CFS correlated strongly with ECOG performance 
status; CFS 4-6 patients were more likely to stop subsequent chemotherapy after just 1 cycle, 
and treatment was more likely to be complicated by admission to hospital. Following this, CFS 
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assessment was introduced earlier in the patient pathway, measured at diagnosis and recorded 
as part of MDT minutes. During this process the team further engaged with geriatric services 
available in the hospital. At present, a protocol for a prospective cohort of lung cancer is 
currently in development to define the patient groups most at risk and therefore most in need of 
early intervention. This will include several systematically health and frailty assessments. Next 
steps include plans to develop an onco-geriatric clinic for pre-frail and frail lung cancer patients. 
 
The University of Sheffield coordinated the multicentre Bridging the Age Gap study which 
aimed to optimise the management of older women with operable breast cancer, reducing the 
age-related gap in cancer outcomes seen between older and younger women. This study 
collected data on over 3400 older women (70+) with operable breast cancer from 57 sites across 
the UK. Recruitment was completed in June 2018 and analysis is on-going. The study collected 
real-world data on measures of comorbidity, quality of life and functional status/frailty, in 
addition to treatment and outcome data (survival and quality-of-life) to identify potential areas 
for improvements in practice. The study also designed and developed decision support tools for 
clinicians and patients based on cancer registry data (36), which are freely available online (37). 
The risk and outcome prediction data are stratified by patient and tumour characteristics to aid 
in treatment decision making by providing more personalised outputs. These were assessed via 
a clustered randomised controlled trial nested within the main study.  
The University of Sheffield has also recently launched a new Institute, the Healthy Lifespan 
Institute (HELSI) in 2019. This aims to bring together researchers from across the University 
to develop cross disciplinary research across the range of age and multimorbidity disciplines 
and has research focused on the biology and genetics of aging, psychology of aging, big data 
and machine learning to handle large datasets to better understand aspects of aging and links 
with engineering to understand how to measure frailty and its treatments.  
 
8.2- Scotland 
NHS Scotland is comprised of 14 territorial health boards which serve a population of 
approximately 5.4 million people.  Cancer care is divided into 3 geographical cancer networks 
(west, south-east and north-east) delivering cancer care in conjunction with local cancer teams. 
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West of Scotland 
The Beatson West of Scotland Cancer Centre is the largest cancer centre in Scotland, and it 
serves 60% of the Scottish population. It hosts the Cancer for Older Persons Service, which is 
the only dedicated geriatric oncology service within the West of Scotland. The service was first 
established in 2016 with MacMillan funding and led by two consultant geriatricians supported 
by a full time Elderly Care Haematology Liaison Nurse Specialist. More recently in 2019, the 
service was expanded for older patients with solid tumours with the appointment of an Elderly 
Care Oncology Liaison Nurse Specialist. This service is multi-disciplinary and is comprised of 
geriatricians, oncologists, physiotherapists, occupational therapists, palliative and pastoral care. 
Patients aged 65+ with a diagnosis of cancer requiring specialist expertise may be referred. This 
includes patients requiring expertise in management of co-morbidities and polypharmacy, 
impaired mobility and falls, cognitive impairment, functional difficulties impairing activities of 
daily living, incontinence and complex discharge planning. This service has evolved 
predominantly within the inpatient setting. However, it also provides outpatient review for older 
cancer patients with a weekly consultant geriatrician- or nurse specialist-led clinic. Moreover, 
a weekly MDT provides an opportunity to discuss and review more complex cases. In 2019, a 
total of 244 inpatients were reviewed by the service with fewer outpatient reviews. However, 
an internal audit of inpatients revealed that a significant proportion of older patients which 
satisfy the referral criteria were not referred. To address the under-utilisation of this service, 
efforts have focussed on improving service uptake through a number of initiatives and projects: 
the development of a geriatric focussed educational programme, raising awareness on the 
benefits of early integration of specialist geriatric care, and more recently, the implementation 
into routine practice of an electronic frailty screening tool for patients admitted via the Acute 
Oncology Assessment Unit which is currently being piloted. 
 
North and South-East of Scotland 
Despite the recognition for service development to meet the needs of older cancer patients in 
these regions, at present there is no established service. However, the Oncology and Palliative 
Medicine departments in Ninewells Hospital, Dundee, started a collaboration in 2019 to 
develop a pilot enhanced supportive care clinic for patients with advanced cancer who are due 
to commence anti-cancer treatment. This multi-disciplinary clinic co-led by a Medical 
Oncologist and a Palliative Care Consultant will be based around the principles of Realistic 
Medicine which has been highlighted as a priority by the Scottish Government and is planned 
to include a CGA with capacity and expertise for personalised targeted interventions. 
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8.3- Wales 
NHS Wales is comprised of 7 territorial health boards which serve a population of 
approximately 3.1 million people with most of its population concentrated in the south. The 
Wales Cancer Network provides a single, patient-focused, clinically-led organisation 
integrating Welsh Government, all Health Boards and cancer service stakeholder groups.  
 
North Wales 
The Betsi Cadwaladr University Health Board launched in October 2019 the first pilot prehab 
programme aimed at cancer patients. This is delivered in a local leisure centre and the team 
consists of an occupational therapist, physiotherapist, and dietician, who run three sessions a 
week. The sessions consist of supervised exercise sessions, respiratory muscle training, diet 
education, and anxiety management. It is aimed at patients undergoing surgery for upper-GI 
and colorectal cancer.  
 
South East of Wales 
In the University Hospital of Llandough in Cardiff, the first onco-geriatrics service was set-up 
in 2017. In order to implement this service in breast cancer, a core team comprised of a breast 
surgeon consultant, a geriatrics trainee and two breast cancer nurses, attended a Leadership in 
Improvement programme. It was felt appropriate that breast cancer was the first cancer group 
to develop this service as it is a neater model, with less emergencies unlike some of the other 
cancer groups. The Edmonton Frailty score is used for all patients aged 70+ and this is used 
quite early on the pathway, since it is used for all patients with a potential diagnosis of breast 
cancer at their initial one stop assessment clinic. The geriatrician also attends the weekly Breast 
multidisciplinary team meeting where the frailty score is available. After the breast cancer 
diagnosis is confirmed, if the patient was screened as frail (defined as a score >6) then an 
appointment is made with the geriatrician and the patient undergoes a CGA. The 
implementation of this service has changed not just the assessment but also the management of 
older breast cancer patients in the region. Moreover, the team is currently collaborating with 
the primary care to link this service with a prehabilitation programme. 
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South West of Wales 
In the South West Wales Cancer Centre in Swansea, the Health Education and Improvement 
Wales funded in 2019 a Clinical Leadership Fellow to spend a year out of programme to 
investigate the unmet needs of older cancer patients. The post was filled by a geriatric medicine 
registrar who aimed at reviewing service models and local frailty services to see how best to 
serve this population. Under the auspices of this fellowship, a single geriatrician-led pilot was 
in place between January and March 2020 which focused on patients with upper gastro-
intestinal cancer of any age, with co-morbidities and/or polypharmacy. Patients underwent a 
systems review, medication review, assessment of falls risk and bone health, and cognitive 
assessment. Data from this pilot will be used to support a business case for the continuation of 
this service hopefully integrated with other local services for older people.  
Prehabilitation programmes are also being widely developed in the region. A study performed 
in South Wales demonstrated that cancer patients are more likely to have conditions requiring 
intervention and optimisation at the point of referral from primary care (38). Therefore, patients 
with suspected lung cancer are now being offered prehabilitation classes led by physiotherapists 
in secondary and tertiary care centres. As many patients live in rural communities far from 
teaching hospitals, classes continue locally after an initial assessment. Similar group classes are 
being developed for older gynaecological cancer patients, with a focus on continence, exercise 
tolerance, and sexual function.  
 
8.4- Northern Ireland 
Health and Social Care in Northern Ireland is the designation of the service that provides care 
for this population of 1.9 million, about 2.8% of the whole UK population (39). Unfortunately, 
between January 2017 and January 2020 there was a collapse of the devolved administration in 
Northern Ireland, with no responsible minister. This had a significant impact in the health 
service, which has been managing for several continuous years on a day-to-day basis. Within 
oncology, the 62-day ministerial target whereby a cancer patient must begin treatment within 
62 days of referral for a suspected cancer has not been met in over three years by any health 
trust, with the most recent figure being 48% for September 2019 (40).  
 
The Northern Ireland Cancer Network (NICAN) aims to deliver improvements in outcomes, 
enhance experience and deliver excellence within cancer care in the region. Unfortunately, in 
this context there are no projects or a health care strategy specific for the geriatric oncology 
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population. Moreover, within the 5 health trusts in Northern Ireland, there are no specific 
projects or guidance about the older patient with cancer. Similarly, in the research sphere there 
are no dedicated regional projects either. However, in conjunction with a local cancer charity, 
the Belfast Health and Social Care Trust (BHSCT) has launched a pilot of a patient-reported 
outcomes app called Noona. This app can be used for audit and data purposes, which may 
provide a useful insight about how older cancer patients are being treated and their associated 
toxicities. A downfall is that this app is limited to those on treatment with systemic anti-cancer 
therapy in the larger cancer centre within the region, therefore not providing any information 
about those not suitable for treatment as well as those having options such as surgery or 
radiotherapy.  
 
9- Conclusion 
The care of older patients is a significant part of daily practice in oncology across the UK. 
However, in the vast majority of centres, the routine care of these patients does not yet include 
a formal multidisciplinary geriatric or frailty assessment/management. Similarly, the use of 
treatment toxicity prediction tools to help guide treatment decisions is not standard practice. 
Even where there are specialist services who care for older patients, integration with oncology 
is usually limited. Despite all these observations, there is a widespread acceptance that a more 
specialized and multi-disciplinary support is required for this patient population. It is therefore 
encouraging to see that over the past 5 years, geriatric oncology is now being considered within 
the UK health care strategies and new services and collaborative projects are growing 
sustainably across most regions. The models of care are still very heterogeneous and adapted 
to the local priorities, needs and resources available. Establishing links between oncology 
services and services in the primary care/community or even secondary care are crucial. 
Hopefully the next 5 years will show further developments as the teams and trusts across the 
UK witness, acknowledge and share the benefits of dedicated onco-geriatrics practice.   
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